UCB's Global Corporate Website
Welcome to UCB in the United States

Nov

14

UCB announces U.S. FDA acceptance of new drug application and EMA MAA validation for zilucoplan for the treatment of generalized myasthenia gravis in adult patients

Nov

11

United for Veterans and our Employees Who Serve

United for Veterans is one of UCB’s Employee Resource Groups (ERGs) focused on veterans and veteran supporters. United for Veterans leverages the combined strength of UCB’s veterans and veteran supporters by encouraging through shared experiences, celebrating veterans’ diversity, inspiring professional development, and honoring veteran communities through servant leadership opportunities while fulfilling our company goals and diversity, equity, and inclusion ambition.

Nov

10

Bimekizumab Demonstrated Sustained Clinical Responses to Week 52 in Phase 3 Studies in Psoriatic Arthritis, Non-Radiographic Axial Spondyloarthritis, and Ankylosing Spondylitis

Nov

09

Moving the Conversation Forward in Rheumatology – UCB at ACR Convergence 2022

Nov

08

UCB Reinforces Commitment to Rheumatology With 15 Abstracts Including New Late-Breaking Data at ACR Convergence 2022

Oct

12

Advancing Science to Better Care for Epilepsy Patients

Oct

10

Using Data and Technology to Enable Better Patient Care

UCB has been rapidly investing in our digital business transformation to unleash the power of digital innovation to help achieve better outcomes for patients, faster.

Sep

26

UCB U.S. Headquarters in Atlanta Awarded Prestigious LEED Gold WELL Platinum Certifications

Sep

26

UCB Achieves Two Awards Recognizing our Sustainability Efforts for the Atlanta Warehouse Expansion

Sep

22

UCB presents latest data from generalized myasthenia gravis portfolio at AANEM meeting